, APAC
103 views

Swiss Re suffers $248m net loss in Q1

The firm logged a ROE of –4.6%.

Swiss Re suffered a $248m loss in profits in the first quarter of 2022, impacted by the war in Ukraine, heightened financial market volatility and the ongoing COVID-19 pandemic.

The firm reported a return of equity (ROE) of -4.6% for Q1. This was a huge drop from its net income of $333m and ROE of 5.2% for the same period in 2021.

The group said it absorbed higher-than-expected large natural catastrophe claims of $524m across its property and casualty businesses as well as COVID-19 claims of $515m. In addition, Swiss Re booked $283m in reserves related to the war in Ukraine.

Swiss Re, however, reported a growth in net premiums earned and fee income for the group by 4% compared to last year to $10.6b in Q1

Swiss Re's return on investments of 0.7% was impacted by equity mark-to-market losses as well as modest losses on Russia-related exposures. The recurring income yield of 2.1% demonstrates the quality and stability of the underlying asset portfolio.

According to the insurer, its capital position remained very strong, with the group Swiss Solvency Test (SST) ratio in the upper half of the 200–250% target range as of 1 April 2022.

You may also like:

Singapore risks protection gap for older population

520,944 properties in Australia to be uninsurable by 2030

Coface appoints new APAC chief

Follow the link for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.